KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $2.47.

  • Amgen's EPS (Basic) rose 11111.11% to $2.47 in Q4 2025 from the same period last year, while for Dec 2025 it was $14.33, marking a year-over-year increase of 8805.77%. This contributed to the annual value of $14.33 for FY2025, which is 8805.77% up from last year.
  • Amgen's EPS (Basic) amounted to $2.47 in Q4 2025, which was up 11111.11% from $5.98 recorded in Q3 2025.
  • In the past 5 years, Amgen's EPS (Basic) ranged from a high of $5.98 in Q3 2025 and a low of -$0.21 during Q1 2024
  • Over the past 5 years, Amgen's median EPS (Basic) value was $2.77 (recorded in 2021), while the average stood at $2.85.
  • In the last 5 years, Amgen's EPS (Basic) crashed by 10394.72% in 2024 and then soared by 163333.33% in 2025.
  • Quarter analysis of 5 years shows Amgen's EPS (Basic) stood at $3.36 in 2021, then dropped by 10.12% to $3.02 in 2022, then plummeted by 52.32% to $1.44 in 2023, then decreased by 18.75% to $1.17 in 2024, then surged by 111.11% to $2.47 in 2025.
  • Its EPS (Basic) stands at $2.47 for Q4 2025, versus $5.98 for Q3 2025 and $2.66 for Q2 2025.